C. Ciric
22 Papers
2 Citations
C. Ciric is an academic researcher. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 3, co-authored 8 publications.
Chat about Author
Papers
Adeno-associated virus type 2 in US children with acute severe hepatitis
Venice Servellita,A. Sotomayor Gonzalez,Daryl M. Lamson,A. Foresythe,Hee Jae Huh,Adam L. Bazinet,Nicholas H. Bergman,Robert L. Bull,Karla Garcia,Jennifer S. Goodrich,Kisha Parker,Diana Radune,April Hatada,Chao-Yang Pan,Kyle Rizzo,J. Bradford H. Bertumen,Christina Morales,Paul E. Oluniyi,Jenny Nguyen,Jessica Tan,Doug Stryke,Matthew T. Leslie,Z. Lyons,Hayden D. Hedman,Umesh D. Parashar,Maureen Sullivan,Kelly Wroblewski,M. Steven Oberste,Jacqueline E. Tate,Julia M Baker,David E. Sugerman,Caelin C. Potts,Xiaoyan Lu,Preeti Chhabra,Olivia Almendares,Neha Balachandran,Jordan Cates,Brandi Freeman,Anita Kambhampati,Rachel L. Marine,Everardo Vega,Mary E Wikswo,Erin McKeever,David R. Kelly,Julie A. Boom,Leila C. Sahni,Janet A. Englund,Eileen J. Klein,Mary A. Staat,Joshua L Clayton,Natalia Cano,Robert G Blattner,L. Amanda Ingram,Henry Shiau,William J. Britt,Luz Helena Gutierrez Sanchez,C. Ciric,Christina A. Rostad,Jan Vinjé,Hannah L Kirking,Debra A. Wadford,R. Taylor Raborn,Kirsten St. George,Charles Y. Chiu +63 more
TL;DR: In this article , the authors used PCR testing, viral enrichment-based sequencing and agnostic metagenomic sequencing to analyse samples from 16 HAdV-positive cases from 1 October 2021 to 22 May 2022, in parallel with 113 controls.
Pre-existing SARS-CoV-2 immunity influences potency, breadth, and durability of the humoral response to SARS-CoV-2 vaccination
Grace Mantus,Lindsay E. Nyhoff,Venkata Viswanadh Edara,Veronika I. Zarnitsyna,C. Ciric,Maria W. Flowers,Carson Norwood,Madison Ellis,Laila Hussaini,Kelly E. Manning,Kathy Stephens,Evan J. Anderson,Rafi Ahmed,Mehul S. Suthar,Jens Wrammert +14 more
TL;DR: In this article , the authors characterize the humoral response in 27 naive and 40 recovered vaccinees and observe that vaccination induces higher peak titers and improves durability in recovered compared with naive vaccinees.
37
Loss of Pfizer (BNT162b2) Vaccine-Induced Antibody Responses against the SARS-CoV-2 Omicron Variant in Adolescents and Adults
Sneh Gupta,Grace Mantus,Kelly E. Manning,Madison Ellis,Mit Patel,C. Ciric,Austin Lu,Jackson S. Turner,Jane A. O’Halloran,Rachel M. Presti,Devyani Joshi,Ali H. Ellebedy,Evan J. Anderson,Christina A. Rostad,Mehul S. Suthar,Jens Wrammert +15 more
TL;DR: Comparing the magnitude and breadth of humoral immune responses in adolescents and adults 1 month after the two-dose Pfizer (BNT162b2) vaccination found that adolescents demonstrated more robust binding antibody and neutralization responses against the wild-type SARS-CoV-2 virus spike protein contained in the vaccine.
16
Effectiveness of Maternal mRNA COVID-19 Vaccination During Pregnancy Against COVID-19–Associated Hospitalizations in Infants Aged <6 Months During SARS-CoV-2 Omicron Predominance — 20 States, March 9, 2022–May 31, 2023
Regina M. Simeone,Laura D. Zambrano,Natasha B. Halasa,Katherine E. Fleming-Dutra,Margaret M Newhams,Michael J. Wu,Amber O. Orzel-Lockwood,Satoshi Kamidani,Pia S. Pannaraj,Katherine Irby,Aline B Maddux,Charlotte V. Hobbs,Melissa A. Cameron,Julie A. Boom,Leila C. Sahni,Michele Kong,Ryan Nofziger,Jennifer E. Schuster,Hillary Crandall,Janet R. Hume,Mary A. Staat,Elizabeth H. Mack,Tamara T. Bradford,Sabrina M. Heidemann,Emily R Levy,Shira J. Gertz,Samina Bhumbra,Tracie C. Walker,Katherine Bline,Kelly N. Michelson,Matt S. Zinter,Heidi R. Flori,Angela P. Campbell,Adrienne G. Randolph,Candice Colston,Heather Kelley,Meghan Murdock,Laura Miron,Ronald C. Sanders,Daniel Hakimi,Jaycee Jumarang,Kennis-Grace Mrotek,Liria Muriscot Niell,Natasha Baig,Lexi Petruccelli,Yamila Sierra,Elizabeth Temte,Imogene Thayer,Frances Zorensky,N.K. Baida,Jong-Ha C. Choi,C. Ciric,Mark D. Gonzalez,Bria M. Coates,Heather E. Price,M Stumpf,Maya Clark,Rylie Dittrich,Suden Kucukak,Eve Listerud,Patrick Moran,Noelle M. Drapeau,Brandi A. Johnson,Lacy Malloch,Lora M Martin,Maygan Martin,Kayla Patterson,Cameron Sanders,Shannon Pruitt,Children’s Mercy Kansas City,Melissa Sullivan,Stephanie P Schwartz,Merry L. Tomcany,Chelsea C. Rohlfs,Amber Wolfe,Fatima A. Mohammed,J. N. Reed,Zachary Rusler,Jack Thomas,Cayla Wakser,Kailee N Fernandez,Laura S Stewart,Leenah Abojaib,Molly J. Kyles +83 more
TL;DR: Maternal vaccination during pregnancy provides some protection against COVID-19-related hospitalizations among infants, particularly those aged <3 months, and expectant mothers should remain current with CO VID-19 vaccination to protect themselves and their infants from hospitalization and severe outcomes associated with COvid-19.
14
XBB.1.5 monovalent booster improves antibody binding and neutralization against emerging SARS-CoV-2 Omicron variants
Shilpi Jain,Sanjeev Kumar,Lilin Lai,Susanne L. Linderman,Ansa A. Malik,Madison L Ellis,Sucheta Godbole,Daniel Solis,Malaya K. Sahoo,Kareem Bechnak,Isabel Paredes,Ralph Tanios,Bahaa Kazzi,Serena M. Dib,Matthew B Litvack,Sonia T. Wimalasena,C. Ciric,Christina Rostad,Richard West,I-Ting Teng,Danyi Wang,Sri Edupuganti,Peter D. Kwong,Nadine Rouphael,Benjamin A. Pinsky,Daniel C. Douek,Jens Wrammert,Alberto Moreno,Mehul S. Suthar +28 more
TL;DR: Data suggest that the XBB.1.1.5 monovalent booster induces cross-reactive antibodies that neutralize XBB.1.1.5 and related Omicron variants.
9